Baseline characteristics
| Sudden death | Controls | P value | |
| (n=27) | (n=1822) | ||
| Age (years) | 72±8 | 67±10 | 0.01 |
| Female (%) | 26 | 39 | 0.231 |
| Body mass index (kg/m²) | 25.0±4.3 | 26.9±4.4 | 0.024 |
| Blood pressure diastolic (mm Hg) | 83±11 | 82±10 | 0.642 |
| Blood pressure systolic (mm Hg) | 148±21 | 145±20 | 0.376 |
| Hypertension (%) | 51 | 59 | 0.442 |
| Pulse rate (beats/min) | 69±10 | 68±11 | 0.681 |
| Patients on simvastatin/ezetimibe (%) | 52 | 50 | 0.998 |
| Ejection fraction (%) | 67±6 | 66±7 | 0.873 |
| LV end diastolic diameter (mm) | 5.1±0.8 | 5.0±0.6 | 0.714 |
| LV end systolic diameter (mm) | 3.2±0.6 | 3.2±0.6 | 0.836 |
| LVMI (g/m²) | 122±49 | 101±31 | 0.001 |
| Jet velocity (m/s) | 3.1±0.5 | 3.1±0.5 | 0.695 |
| Increase peak velocity (m/s)* | 0.52±0.66 | 0.62±0.60 | 0.496 |
| Jet velocity >3.0 m/s (%) | 51 | 48 | 0.699 |
| Mean pressure gradient (mm Hg) | 22±8 | 23±9 | 0.678 |
| Aortic valve area (cm 2 ) | 1.2±0.5 | 1.3±0.5 | 0.338 |
| Creatinine (micromol/L) | 95±15 | 94±16 | 0.636 |
| Haemoglobin (g/L) | 137±16 | 139±12 | 0.383 |
| Glucose (mmol/L) | 5.3±1.0 | 5.3±0.8 | 0.809 |
LV, left ventricular; LVMI, left ventricular mass index.